D-0358-2022 Class III Terminated

Recalled by Lupin Pharmaceuticals Inc. — Baltimore, MD

Recall Details

Product Type
Drugs
Report Date
January 12, 2022
Initiation Date
December 29, 2021
Termination Date
August 23, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
23,965 100 count bottles

Product Description

Oxycodone Hydrochloride Tablets, USP C-II, 5 mg, 100 count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202. Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873. NDC 43386-432-01

Reason for Recall

Out-of-specification impurity test result observed at 18-month long term stability time point.

Distribution Pattern

Product Distributed in NY and OH.

Code Information

Lot # S000268, Exp. date January 2022